JANX   $50.26  8.09% Market Closed After Close 50.75 0.97%

Janux Therapeutics Inc
Total Cash 646.29M
totalCashPerShare 12.39
EBITDA -63.86M
Total Debt 23.82M
quickRatio 57.025
currentRatio 57.336
Total Revenue 15.13M
debtToEquity 3.622
Revenue/Share 0.309
ROA -0.07979
ROE -0.09203
grossProfits
freeCashflow -36.22M
operatingCashflow -46.47M
earningsGrowth
revenueGrowth 7.417
grossMargins -2.51035
ebitdaMargins 0.0
operatingMargins -1.55356
profitMargins -2.91168
enterpriseValue 2.24B
forwardPE -35.642857
floatShares 31.60M
sharesOutstanding 52.16M
sharesShort 4.33M
sharesShortPriorMonth 3.31M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.97%
Short Ratio help_outline 6.99%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 12.608
Price To Book help_outline 4.35
earningsQuarterlyGrowth
netIncomeToCommon -44.05M
trailingEps -0.87%
forwardEps -1.54%
enterpriseToEbitda -35.09
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.33 3Q 2024
institutionsCount 222
lastUpdated Nov. 7, 2024, 5:05 a.m.